A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

Clinical trial NCT05683717 · RECRUITING

Trial details

NCT number: NCT05683717
Sponsor: TransThera Sciences (Nanjing), Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Malignancies

Start date: 2023-03-30
Primary completion: 2026-10-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.